NCT06309992: A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
- State
- Completed
- Phase
- Phase 3
- People
- 218 taking part
- Started
- 2 Apr 2024
- Primary completion
- 9 Oct 2025
- Arms
- Treatment arm
- Results
- None posted
- Papers
- doi:10.1111/apt.70020
- 13 Mar 2024: Trial registered
- 2 Apr 2024: Trial started
- 2 Dec 2025: Trial completed